Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (171-180 of 297) with videos related to

Pageof 30
Sort By:
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|December 25, 2010
[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder]Reiji Yoshimura, Atsuko Ikenouchi-Sugita, Hikaru Hori, et al.
Translational Psychiatry|June 12, 2020
An independent component analysis reveals brain structural networks related to TNF-α in drug-naïve, first-episode major depressive disorder: a source-based morphometric studyShingo Kakeda, Keita Watanabe, Hoa Nguyen, et al.
Journal of Occupational and Environmental Medicine|October 26, 2019
Validity and Responsiveness of the Work Functioning Impairment Scale in Workers With DepressionKei Tokutsu, Shingo Kawazoe, Asuka Katsuki, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 19, 2011
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with vareniclineWakako Umene-Nakano, Reiji Yoshimura, Chiharu Yoshii, et al.
Neuropsychiatric Disease and Treatment|April 28, 2025
Associations of Vocal Features, Psychiatric Symptoms, and Cognitive Functions in SchizophreniaTomoya Natsuyama, Enkhmurun Chibaatar, Yuko Shibata, et al.
Frontiers in Psychiatry|January 23, 2023
Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptomsTomoya Natsuyama, Naomichi Okamoto, Keita Watanabe, et al.
Journal of Psychopharmacology (Oxford, England)|October 15, 2009
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphismWakako Umene-Nakano, Reiji Yoshimura, Nobuhisa Ueda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 21, 2012
Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorderReiji Yoshimura, Taro Kishi, Hikaru Hori, et al.
Annals of General Psychiatry|January 25, 2012
Steroid psychosis in a polyarteritis nodosa patient successfully treated with risperidone: tracking serum brain-derived neurotrophic factor levels longitudinallyReiji Yoshimura, Kosuke Saito, Tadanori Terada, et al.
Journal of Affective Disorders|March 23, 2024
Volume enlargement of the choroid plexus and brain ventricles in drug-naïve, first-episode major depressive disorderGaku Hayasaki, Enkmurun Chibaatar, Keita Watanabe, et al.
Pageof 30

Showing results (171-180 of 297) with videos related to

Sort By:
Pageof 30
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|December 25, 2010
[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder]Reiji Yoshimura, Atsuko Ikenouchi-Sugita, Hikaru Hori, et al.
Translational Psychiatry|June 12, 2020
An independent component analysis reveals brain structural networks related to TNF-α in drug-naïve, first-episode major depressive disorder: a source-based morphometric studyShingo Kakeda, Keita Watanabe, Hoa Nguyen, et al.
Journal of Occupational and Environmental Medicine|October 26, 2019
Validity and Responsiveness of the Work Functioning Impairment Scale in Workers With DepressionKei Tokutsu, Shingo Kawazoe, Asuka Katsuki, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 19, 2011
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with vareniclineWakako Umene-Nakano, Reiji Yoshimura, Chiharu Yoshii, et al.
Neuropsychiatric Disease and Treatment|April 28, 2025
Associations of Vocal Features, Psychiatric Symptoms, and Cognitive Functions in SchizophreniaTomoya Natsuyama, Enkhmurun Chibaatar, Yuko Shibata, et al.
Frontiers in Psychiatry|January 23, 2023
Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptomsTomoya Natsuyama, Naomichi Okamoto, Keita Watanabe, et al.
Journal of Psychopharmacology (Oxford, England)|October 15, 2009
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphismWakako Umene-Nakano, Reiji Yoshimura, Nobuhisa Ueda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 21, 2012
Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorderReiji Yoshimura, Taro Kishi, Hikaru Hori, et al.
Annals of General Psychiatry|January 25, 2012
Steroid psychosis in a polyarteritis nodosa patient successfully treated with risperidone: tracking serum brain-derived neurotrophic factor levels longitudinallyReiji Yoshimura, Kosuke Saito, Tadanori Terada, et al.
Journal of Affective Disorders|March 23, 2024
Volume enlargement of the choroid plexus and brain ventricles in drug-naïve, first-episode major depressive disorderGaku Hayasaki, Enkmurun Chibaatar, Keita Watanabe, et al.
Pageof 30